Verrica Pharmaceuticals Inc. SEC filings VRCA
Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 24, 2025 | Nov 23, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 30, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Jul 23, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 21, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 30, 2025 | Jan 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 4, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Oct 8, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2024 | Aug 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2024 | Aug 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 5, 2024 | Aug 2, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 28, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 15, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 24, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 21, 2023 | Feb 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2022 | Sep 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Other events
|
Jul 13, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 1, 2022 | Jun 29, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs
|
Jun 3, 2022 | May 31, 2022 |
| 8-K |
Current report
Other events
|
May 25, 2022 | May 24, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Other events
|
Dec 15, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2021 | Sep 29, 2021 |
| 8-K |
Current report
Other events
|
Sep 20, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Other events
|
May 28, 2021 | May 28, 2021 |
| 8-K |
Current report
Results of operations
|
May 7, 2021 | May 7, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 23, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 17, 2021 | Mar 17, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Other events
|
Feb 17, 2021 | Feb 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Other events
|
Dec 23, 2020 | Dec 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2020 | Sep 8, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2020 | Aug 7, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2020 | Jul 22, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 14, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Other events
|
Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 11, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 10, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 17, 2020 | Apr 17, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
|
Mar 13, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2020 | Mar 2, 2020 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2020 | Jan 10, 2020 |
| 8-K |
Current report
Listing notice
|
Nov 20, 2019 | Nov 20, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2019 | Oct 18, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2019 | Oct 18, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2019 | Oct 4, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 4, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2019 | Jul 1, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2019 | Jun 26, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 14, 2019 | Jun 13, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2019 | Jun 12, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2019 | Apr 12, 2019 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Other events
|
Mar 7, 2019 | Mar 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2019 | Jan 3, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2018 | Nov 7, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2018 | Sep 12, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2018 | Aug 7, 2018 |
| 8-K |
Current report
Material agreement
|
Jul 19, 2018 | Jul 16, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 19, 2018 | Jun 19, 2018 |
Showing 110 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRCA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Chester, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1660334
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.